Global Oligo Synthesis Market Growth (Status and Outlook) 2024-2030

Global Oligo Synthesis Market Growth (Status and Outlook) 2024-2030

Oligo synthesis, also known as oligonucleotide synthesis, is a laboratory technique used to chemically synthesize short sequences of nucleic acids, typically DNA or RNA oligonucleotides. These oligonucleotides are composed of relatively short chains of nucleotides, usually less than 100 bases in length. Oligos (or oligonucleotides) are commonly used as primers in PCR (polymerase chain reactions) to selectively amplify target DNA sequences. They can be tagged with fluorescent dyes or radioisotopes for detection purposes. Oligos are often used in DNA sequencing, gene synthesis, and genetic testing, and can be modified for gene therapies or gene expression.

The global Oligo Synthesis market size is projected to grow from US$ 685 million in 2024 to US$ 1353 million in 2030; it is expected to grow at a CAGR of 12.0% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Oligo Synthesis Industry Forecast” looks at past sales and reviews total world Oligo Synthesis sales in 2022, providing a comprehensive analysis by region and market sector of projected Oligo Synthesis sales for 2023 through 2029. With Oligo Synthesis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligo Synthesis industry.

This Insight Report provides a comprehensive analysis of the global Oligo Synthesis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oligo Synthesis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oligo Synthesis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligo Synthesis and breaks down the forecast by Type, by End User, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligo Synthesis.

Global key players of Oligo Synthesis include Thermo Fisher Scientific, Merck, Genscript, BBI Life Sciences, Integrated DNA Technologies (IDT), etc. The top five players hold a share about 44%. North America is the largest market, and has a share about 53%, followed by Asia-Pacific and Europe with share 25% and 15%, separately. In terms of product type, Common Primer Synthesis is the largest segment, occupied for a share of 64%. In terms of end user, Biotech Company has a share about 75 percent.

This report presents a comprehensive overview, market shares, and growth opportunities of Oligo Synthesis market by product type, application, key players and key regions and countries.

Segmentation by Type:
Common Primer Synthesis
Modified Primer Synthesis

Segmentation by End User:
Biotech Company
Academic Scientific Research Institution

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Common Primer Synthesis
Modified Primer Synthesis

Segmentation by End User:
Biotech Company
Academic Scientific Research Institution

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Merck
Azenta Life Sciences
BBI Life Sciences
TriLink BioTechnologies
Aurigene Pharmaceutical Services
Integrated DNA Technologies (IDT)
Cusabio
Macrogen
Synbio Technologies
Eurogentec
Genscript
Abace Biotechnology
Tsingke
Guangzhou RiboBio
Atantares
Wuhan GeneCreate Biological Engineering
Beyotime
General Biol
Biosune

Please note: The report will take approximately 2 business days to prepare and deliver.